Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Total Net Revenue $ 1,281,682 $ 3,570,035 $ 3,085,106 $ 6,333,237
Total Cost of Sales 861,668 2,154,138 1,851,043 3,930,778
Gross Profit 420,014 1,415,897 1,234,063 2,402,459
Operating Expenses:        
Research and development 291,849 425,670 661,092 912,296
Selling, general and administrative 1,056,721 1,476,719 2,127,331 2,799,767
Depreciation and amortization 14,743 17,043 29,538 33,975
Total Operating Expenses 1,363,313 1,919,432 2,817,961 3,746,038
Operating Loss (943,299) (503,535) (1,583,898) (1,343,579)
Other Expenses:        
Interest expense, net (6,904) (15,040) (15,584) (20,600)
Total Other Expenses (6,904) (15,040) (15,584) (20,600)
Loss before Provision for Income Taxes (950,203) (518,575) (1,599,482) (1,364,179)
Income Tax Provision (Benefit) (106) 0 3,116 0
Net Loss Attributable to Common Stockholders $ (950,097) $ (518,575) $ (1,602,598) $ (1,364,179)
Net Loss per Common Share:        
Basic - Net Loss Attributable to Common Stockholders $ (0.01) $ (0.00) $ (0.01) $ (0.01)
Diluted - Net Loss Attributable to Common Stockholders $ (0.01) $ (0.00) $ (0.01) $ (0.01)
Weighted Average Common Shares Outstanding - basic 136,311,335 135,085,519 135,814,956 134,477,460
Weighted Average Common Shares Outstanding - diluted 136,311,335 135,085,519 135,814,956 134,497,822
Product [Member]        
Total Net Revenue $ 1,103,371 $ 3,380,892 $ 2,712,633 $ 5,967,561
Total Cost of Sales 835,871 2,077,066 1,802,474 3,767,664
Recurring [Member]        
Total Net Revenue 178,311 189,143 372,473 365,676
Total Cost of Sales $ 25,797 $ 77,072 $ 48,569 $ 163,114